S&P 500
5.187,67 -0,03 (-0,00%) Nasdaq
16.302,76 -29,80 (-0,18%) NIKKEI 225
38.236,02 +33,65 (+0,09%) Dólar/Euro
1,0747 -0,0005 (-0,04%) Petróleo Brent
83,89 +0,31 (+0,37%) Bitcoin EUR
57.233,90 -1.131,83 (-1,94%)
La lucha contra la COVID19
23,81k seguidores • 14 símbolos Lista de control de TREA
Sigue esta lista para descubrir y hacer seguimiento de las acciones de las empresas que cotizan en bolsa y que tienen planes de tratamiento y atención sanitaria relacionados con COVID-19.
Gestionada por TREA
Rendimiento
| Lista de control | Cambio de hoy | Rendimiento 1 mes | Rendimiento 1 año | Rendimiento total |
|---|---|---|---|---|
| La lucha contra la COVID19 | -0.42% | - | - | - |
| ^GSPC | -0.00% | -0.43% | +25.94% | +5478.14% |
14 símbolos
| Símbolo | Nombre de la empresa | Último precio | Cambio | Cambio de % | Tiempo de mercado | Volumen | Vol medio (3 meses) | Capitalización de mercado |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 148.95 | +0.23 | +0.15% | 16:00 GMT-4 | 7,09M | 7,61M | 358,47B |
| ABBV | AbbVie Inc. | 160.45 | -2.10 | -1.29% | 16:00 GMT-4 | 5,76M | 5,73M | 283,33B |
| PFE | Pfizer Inc. | 28.27 | +0.50 | +1.80% | 16:01 GMT-4 | 38,65M | 42,62M | 160,19B |
| SNY | Sanofi | 50.1 | +0.53 | +1.07% | 16:00 GMT-4 | 1,60M | 2,02M | 125,21B |
| REGN | Regeneron Pharmaceuticals, Inc. | 955.76 | -14.21 | -1.46% | 16:00 GMT-4 | 388,97k | 463,62k | 105,31B |
| GSK | GSK plc | 44.14 | -0.01 | -0.02% | 16:00 GMT-4 | 2,01M | 3,32M | 90,19B |
| GILD | Gilead Sciences, Inc. | 64.92 | -0.54 | -0.82% | 16:00 GMT-4 | 5,09M | 7,20M | 80,95B |
| MRNA | Moderna, Inc. | 121.89 | +0.82 | +0.68% | 16:00 GMT-4 | 2,50M | 3,88M | 46,71B |
| TAK | Takeda Pharmaceutical Company Limited | 13.06 | -0.22 | -1.66% | 16:00 GMT-4 | 1,56M | 1,65M | 41,09B |
| BNTX | BioNTech SE | 90.13 | -0.75 | -0.83% | 16:00 GMT-4 | 338,31k | 603,19k | 21,72B |
| VIR | Vir Biotechnology, Inc. | 9.54 | -0.39 | -3.93% | 16:00 GMT-4 | 986,85k | 1,05M | 1,30B |
| NVAX | Novavax, Inc. | 4.47 | -0.14 | -3.04% | 16:00 GMT-4 | 3,05M | 6,86M | 627,60M |
| INO | Inovio Pharmaceuticals, Inc. | 11 | -0.15 | -1.35% | 16:00 GMT-4 | 157,20k | 458,12k | 284,97M |
GuruFocus.comDecoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight
Unraveling the Financial Dynamics and Strategic Directions of Gilead Sciences Inc (GILD)
BenzingaSecond Death - Pfizer Reports Young Boy's Death After One Year Of Gene Therapy Treatment In Muscle Wasting Disorder Trial
A young patient died due to cardiac arrest after receiving Pfizer Inc’s (NYSE:PFE) experimental gene therapy in a mid-stage trial for Duchenne muscular dystrophy (DMD), the company told in a letter to Parent Project Muscular Dystrophy. The boy was enrolled in Phase 2 DAYLIGHT study studying the treatment in boys at least two years old and under four years old. The patient received the investigational gene therapy, fordadistrogene movaparvovec (PF-06939926), in early 2023. Citing Pfizer, Reuters
Barrons.comTeva Stock Powers Ahead as Schizophrenia News Offsets Mixed Earnings
Shares of Teva Pharmaceutical Industries were climbing yet again on Wednesday, after the company announced positive results in a trial of a schizophrenia medicine. Its quarterly results, also disclosed early Wednesday, were mixed. Revenue was $3.8 billion for the quarter, slightly better than the FactSet consensus estimate of $3.7 billion, while non-GAAP diluted earnings were 48 cents a share.
